Continue
By using our website you accept our cookies policy.Find out more

China Life Sciences Market Access Roadshow 2018

Posted on 09/01/2018

Event dates: 6 - 13 March 2018

Opportunity for UK medical technology and pharmaceutical companies to learn the latest about the Chinese life science market

China Context:
• Rapidly growing economy
• changing demographics (wealth, lifestyles and age)
• increasing/healthcare disease burden
• strong government focus on healthcare and rapidly growing government and private spend

In the context of progressive change in the Chinese life science market, and a growing interest from UK companies, the UK Department for International Trade is organising a series of one-day seminars across the UK. These events will feature expert speakers on important topics for UK businesses that are considering exports/operations in China, or that are already active there. The series is planned as follows:

Week 1
• Tues 6 March – London
• Wed 7 March – Cardiff (at BioWales*)
• Thurs 8 March – Manchester

Week 2
• Mon 12 March – Edinburgh
• Tues 13 March – Birmingham

Draft agenda topics:
• China healthcare and life science industry overview – latest information and opportunity areas
• regulatory change, product registration and navigating the CFDA
• routes to market: joint ventures, licensing deals, distribution, wholly owned foreign enterprise
• intellectual property protection
• case studies from UK companies already active in China
• networking
• TBC: opportunity to meet a small delegation of Chinese companies in the afternoon that offer product registration services/assistance
• support available from government and other organisations

To express an interest in attending, please email: ditlifesciences@brayleino.co.uk

*Weds 7th at BioWales: Advice on accessing the Chinese Life Science Market will be available at the DIT exhibition stand. Whilst there will be no charge from DIT for this service, entry to the BioWales event is required to access

You might be interested in this: UK and China to fund new collaborative projects to tackle antimicrobial resistance